Decision Diagnostics Corp (DECN)

[rawman]

Here is the evidence which supports the earlier claim that DECN is in the process of submitting a PRE-EUA APPLICATION for the first iteration of the Gen Viro test kit, which uses the impedance technology. The quote was copied directly from DECN's Supplement Information Statement, which is posted on OTCMARKET.COM.

The current development cycle is considered advanced development. For FDA EUA filing and the granting of a Pre-EUA by the FDA, the company is preparing its final working concept filing, to be completed within days of this writing.

It is anticipated that a full regular Emergency Use Authorization (EUA) Application will be transmitted to the FDA at a yet to be determined future date.

THE ABOVE QUOTE WAS POSTED ON MARCH 31, 2020.